| Dr Regine B Feuer, MD | |
|
10810 Connecticut Ave, Kensington, MD 20895-2138 | |
| (301) 929-7100 | |
| (301) 929-7114 |
| Full Name | Dr Regine B Feuer |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 10810 Connecticut Ave, Kensington, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710042106 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D34200 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Regine B Feuer, MD 2101 E Jefferson St, Kaiser Permanente Ppqa Dept 6 West Attn Theresa Brooks, Rockville, MD 20852-4908 Ph: (301) 816-6660 | Dr Regine B Feuer, MD 10810 Connecticut Ave, Kensington, MD 20895-2138 Ph: (301) 929-7100 |
News Archive
Corals first appeared on earth nearly half a billion years ago during the Cambrian Period of the Paleozoic Era. The ancient Greek philosopher Aristotle categorized corals as zoophyta, or "plant-animals", due to their plant-like appearance.
Scientists from the University of Southampton have discovered that copper and copper alloys rapidly destroy norovirus - the highly-infectious sickness bug.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Mercy Health Services has selected its ProVation MD software for gastroenterology procedure documentation and coding. The software will be deployed in the Institute for Digestive Health and Liver Disease at Mercy.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that it has submitted a Clinical Trial Authorization application to the Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 study of ALN-AAT02, an investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease.
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
› Verified 4 days ago
Dr. Barbara A Turner, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7114 | |
Margarita Litvak-kelner, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 301-929-7100 | |
Dr. Paul E Lewis Ii, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 10810 Connecticut Ave, Kaiser Permanente Kensington Medical Center, Kensington, MD 20895 Phone: 301-929-7100 | |
Dr. Erica E Singelmann, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 301-929-7100 | |
Dr. Nikhila Iruku, D.O Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 301-929-7100 | |
Dr. Madelaine Odette Rosche-scott, M.D Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Avenue, Department Of Obgyn, Kensington, MD 20895 Phone: 202-853-2152 | |
Connie Lele Liang, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 301-929-7001 |